jm 221 has been researched along with Leukemia L 1210 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnard, CF; Giandomenico, CM; Harrap, KR; Murrer, BA; Nicolson, MC; O'Neill, CF; Orr, RM; Vollano, JF | 1 |
Chwalinski, T; Harrap, KR; Kelland, LR; O'Neill, CF; Ormerod, MG; Orr, RM; Titley, JC | 1 |
2 other study(ies) available for jm 221 and Leukemia L 1210
Article | Year |
---|---|
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Division; Cell Survival; Cisplatin; DNA, Neoplasm; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Organoplatinum Compounds; Tumor Cells, Cultured | 1994 |
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum | 1996 |